Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals

[1]  S. Smeland,et al.  Cancer risk with folic acid supplements: a systematic review and meta-analysis , 2012, BMJ Open.

[2]  R. Garrick.  Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial , 2011 .

[3]  P. Galan,et al.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[4]  R. Collins,et al.  Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. , 2010, Archives of internal medicine.

[5]  E. Castilla,et al.  Folic acid flour fortification: Impact on the frequencies of 52 congenital anomaly types in three South American countries , 2010, American journal of medical genetics. Part A.

[6]  G. Hankey.  B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial , 2010, The Lancet Neurology.

[7]  R. Collins,et al.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. , 2010, JAMA.

[8]  A. Kibel,et al.  Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial , 2010 .

[9]  W. Willett,et al.  A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. , 2009, The American journal of clinical nutrition.

[10]  S. Vollset,et al.  Cancer incidence and mortality after treatment with folic acid and vitamin B12. , 2009, JAMA.

[11]  S. Nissen.  Analyses of cancer data from three ezetimibe trials. , 2009, The New England journal of medicine.

[12]  J. Manson,et al.  Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. , 2008, JAMA.

[13]  R. Pattinson,et al.  Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. , 2008, Birth defects research. Part A, Clinical and molecular teratology.

[14]  K. Muir,et al.  Aspirin and folic acid for the prevention of recurrent colorectal adenomas. , 2008, Gastroenterology.

[15]  Trends in wheat-flour fortification with folic acid and iron--worldwide, 2004 and 2007. , 2008, MMWR. Morbidity and mortality weekly report.

[16]  P. Guarino,et al.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. , 2007, JAMA.

[17]  I. Rosenberg,et al.  A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A Hypothesis , 2007, Cancer Epidemiology Biomarkers & Prevention.

[18]  Elizabeth L. Barry,et al.  Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. , 2007, JAMA.

[19]  H. Blom,et al.  Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. , 2004, Blood.

[20]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[21]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[22]  B-Vitamin Treatment Trialists.  Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. , 2006, American heart journal.

[23]  A. Roddam,et al.  Folate intake and colorectal cancer risk: A meta‐analytical approach , 2005, International journal of cancer.

[24]  Young-In Kim.  Will mandatory folic acid fortification prevent or promote cancer? , 2004, The American journal of clinical nutrition.

[25]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[26]  J. Hunter,et al.  Oxford Textbook of Medicine, 4th Edn , 2003 .

[27]  Z. Li,et al.  Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. , 2000, The New England journal of medicine.

[28]  Hong Wang,et al.  Correction: Prevention of Neural-Tube Defects with Folic Acid in China. , 1999, The New England journal of medicine.

[29]  P. Wilson,et al.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.

[30]  M F Huque,et al.  Some comments on frequently used multiple endpoint adjustment methods in clinical trials. , 1997, Statistics in medicine.

[31]  David J. Weatherall,et al.  Oxford textbook of medicine , 1996 .

[32]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[33]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[34]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[35]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[36]  F. Stanley,et al.  Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western Australia , 1989, The Medical journal of Australia.

[37]  D. Weir,et al.  Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. , 1985, Archives of disease in childhood.

[38]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[39]  J. Elwood,et al.  POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION , 1980, The Lancet.

[40]  J. de Swiet.  Letter: Therapy for acute diarrhoea. , 1975, Lancet.

[41]  B. Hibbard.  THE ROLE OF FOLIC ACID IN PREGNANCY * , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.